Michael L. Levitz
Net Worth

Last updated:

What is Michael L. Levitz net worth?

The estimated net worth of Mr. Michael L. Levitz is at least $2,240,467 as of 11 Mar 2024. He owns shares worth $136,787 as insider and has received compensation worth at least $2,103,680 in Anika Therapeutics, Inc..

What is the salary of Michael L. Levitz?

Mr. Michael L. Levitz salary is $525,920 per year as Executive Vice President, Chief Financial Officer & Treasurer in Anika Therapeutics, Inc..

How old is Michael L. Levitz?

Mr. Michael L. Levitz is 51 years old, born in 1974.

What stocks does Michael L. Levitz currently own?

As insider, Mr. Michael L. Levitz owns shares in one company:

Company Title Shares Price per share Total value
Anika Therapeutics, Inc. (ANIK) Executive Vice President, Chief Financial Officer & Treasurer 15,924 $8.59 $136,787

What does Anika Therapeutics, Inc. do?

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

ANIK logo
ANIK
Anika Therapeutics, Inc.
$8.59

Michael L. Levitz insider trading

Anika Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 4,438 N/A N/A
Option
Restricted Stock Unit 8,888 N/A N/A
Option
Restricted Stock Unit 5,875 N/A N/A
Option
Common Stock 8,888 N/A N/A
Option
Restricted Stock Unit 4,438 N/A N/A
Option
Common Stock 5,875 N/A N/A
Option
Common Stock 3,859 N/A N/A
Option
Restricted Stock Unit 3,859 N/A N/A
Option
Common Stock 8,888 N/A N/A
Option
Restricted Stock Unit 8,888 N/A N/A
Option
Restricted Stock Unit 4,439 N/A N/A
Option
Common Stock 4,439 N/A N/A
Option
Common Stock 3,859 N/A N/A
Option
Restricted Stock Unit 3,859 N/A N/A
Purchase
Common Stock 4,000 $24.62 $98,476
Option
Common Stock 4,438 N/A N/A
Purchase
Common Stock 777 $40.21 $31,239
Purchase
Common Stock 2,850 $40.21 $114,587
Option
Restricted Stock Unit 3,859 N/A N/A
Option
Common Stock 3,859 N/A N/A

Anika Therapeutics key executives

Anika Therapeutics, Inc. executives and other stock owners filed with the SEC: